Gena Wang

Stock Analyst at Barclays

(3.34)
# 994
Out of 5,041 analysts
223
Total ratings
45.21%
Success rate
4.09%
Average return

Stocks Rated by Gena Wang

Cellectis
Oct 17, 2025
Maintains: Overweight
Price Target: $4$8
Current: $3.48
Upside: +129.89%
Cytokinetics
Oct 6, 2025
Maintains: Overweight
Price Target: $71$82
Current: $57.83
Upside: +41.79%
Kodiak Sciences
Sep 25, 2025
Upgrades: Equal-Weight
Price Target: $7$17
Current: $18.69
Upside: -9.04%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Overweight
Price Target: $78$80
Current: $70.86
Upside: +12.90%
REGENXBIO
Aug 8, 2025
Maintains: Overweight
Price Target: $50$37
Current: $13.03
Upside: +183.96%
Avidity Biosciences
Aug 8, 2025
Maintains: Overweight
Price Target: $59$62
Current: $49.15
Upside: +26.14%
CRISPR Therapeutics AG
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $42$56
Current: $67.61
Upside: -17.17%
Beam Therapeutics
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $25$21
Current: $27.96
Upside: -24.89%
Moderna
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $40$31
Current: $26.74
Upside: +15.93%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $329$460
Current: $463.43
Upside: -0.74%
Upgrades: Equal-Weight
Price Target: $10$22
Current: $22.81
Upside: -3.55%
Maintains: Equal-Weight
Price Target: $42$46
Current: $66.40
Upside: -30.72%
Maintains: Overweight
Price Target: $15$10
Current: $5.62
Upside: +77.94%
Maintains: Overweight
Price Target: $9$5
Current: $0.63
Upside: +689.52%
Maintains: Overweight
Price Target: $45$38
Current: $11.34
Upside: +235.10%
Maintains: Equal-Weight
Price Target: $8$11
Current: $7.20
Upside: +52.78%
Maintains: Overweight
Price Target: $26$31
Current: $5.98
Upside: +418.39%
Maintains: Overweight
Price Target: $55$26
Current: $25.60
Upside: +1.56%
Maintains: Equal-Weight
Price Target: $435$467
Current: $421.39
Upside: +10.82%
Maintains: Equal-Weight
Price Target: $5$3
Current: $3.72
Upside: -19.35%
Maintains: Overweight
Price Target: $110$86
Current: $54.48
Upside: +57.86%
Maintains: Overweight
Price Target: $83$81
Current: $33.53
Upside: +141.57%
Maintains: Overweight
Price Target: $93$94
Current: $31.86
Upside: +195.04%
Maintains: Equal-Weight
Price Target: $7$9
Current: $17.74
Upside: -49.27%
Upgrades: Equal-Weight
Price Target: $16$25
Current: $11.22
Upside: +122.82%
Maintains: Overweight
Price Target: $32$18
Current: $8.72
Upside: +106.42%
Maintains: Underweight
Price Target: $21$9
Current: $5.23
Upside: +72.08%
Initiates: Buy
Price Target: $275
Current: $5.48
Upside: +4,918.25%